Yutao Liu Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

1/2020	Ocular cytomegalovirus latency exacerbates the development of choroidal neovascularization.
3/2016	PET monitoring angiogenesis of infarcted myocardium after treatment with vascular endothelial growth factor and bone marrow mesenchymal stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yutao Liu Research Topics

Disease

34	Neoplasms (Cancer) 04/2024 - 01/2010
29	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 03/2011
17	Glaucoma 12/2023 - 01/2008
15	Open-Angle Glaucoma (Glaucoma, Open Angle) 11/2019 - 04/2010
10	Adenocarcinoma of Lung 02/2023 - 05/2014
8	Infections 01/2024 - 01/2020
8	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2013
7	Lung Neoplasms (Lung Cancer) 01/2024 - 10/2017
7	Keratoconus 11/2023 - 06/2012
6	Brain Neoplasms (Brain Tumor) 12/2022 - 03/2012
6	Disease Progression 12/2022 - 03/2011
6	Lymphoma (Lymphomas) 07/2022 - 05/2015
5	Parkinson Disease (Parkinson's Disease) 02/2024 - 12/2017
5	Inflammation (Inflammations) 01/2024 - 02/2018
5	Wounds and Injuries (Trauma) 01/2022 - 05/2015
5	Exfoliation Syndrome 01/2018 - 04/2010
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2017 - 06/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 01/2021
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2022 - 10/2017
3	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2016
3	Osteoarthritis 12/2020 - 01/2017
3	Inborn Genetic Diseases (Disease, Hereditary) 12/2017 - 01/2015
2	Alveolar Bone Loss 04/2024 - 02/2023
2	Kidney Diseases (Kidney Disease) 03/2024 - 11/2016
2	Synucleinopathies 02/2024 - 01/2022
2	Heart Failure 11/2023 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 07/2022 - 01/2019
2	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2021 - 12/2019
2	Bone Diseases (Bone Disease) 01/2021 - 08/2020
2	Ataxia (Dyssynergia) 01/2021 - 06/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020 - 10/2017
2	Parkinsonian Disorders (Parkinsonism) 10/2018 - 12/2017
2	Hypoxia (Hypoxemia) 02/2018 - 10/2017
2	Adenocarcinoma 01/2017 - 08/2013
1	Hematologic Neoplasms (Hematological Malignancy) 04/2024
1	Urinary Tract Infections (Urinary Tract Infection) 04/2024
1	Post-Acute COVID-19 Syndrome 01/2024
1	COVID-19 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024
1	Melanoma (Melanoma, Malignant) 01/2024
1	Neuronal intranuclear inclusion disease 01/2024
1	Acute-Phase Reaction 01/2024

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2015
16	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2016
13	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2015
11	Tyrosine Kinase InhibitorsIBA 01/2024 - 08/2013
8	ErbB Receptors (EGF Receptor)IBA 12/2022 - 08/2013
6	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2021
6	Gefitinib (Iressa)FDA Link 01/2018 - 09/2011
5	osimertinibIBA 01/2023 - 01/2018
5	PlatinumIBA 10/2019 - 03/2011
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2020
4	Anaplastic Lymphoma KinaseIBA 01/2024 - 01/2022
4	LigandsIBA 01/2023 - 12/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2011
4	EnzymesIBA 07/2022 - 02/2018
4	Docetaxel (Taxotere)FDA Link 03/2012 - 12/2010
4	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2012 - 01/2008
3	AntigensIBA 04/2024 - 10/2017
3	SynucleinsIBA 02/2024 - 01/2022
3	CrizotinibIBA 06/2023 - 01/2019
3	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2012 - 04/2011
2	LipidsIBA 01/2024 - 01/2010
2	Therapeutic UsesIBA 01/2024 - 01/2016
2	Estrogens (Estrogen)FDA Link 12/2023 - 01/2013
2	HomocysteineIBA 06/2023 - 02/2018
2	Retinaldehyde (Retinal)IBA 02/2023 - 02/2018
2	anlotinibIBA 01/2023 - 02/2021
2	PrionsIBA 01/2023 - 01/2022
2	Immunoglobulin G (IgG)IBA 07/2022 - 01/2020
2	Circulating Tumor DNAIBA 07/2022 - 12/2020
2	AutoantibodiesIBA 07/2022 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 02/2022 - 03/2011
2	apatinibIBA 01/2022 - 01/2020
2	CollagenIBA 11/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 08/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2016
2	betaglycan (TGFBR3)IBA 01/2020 - 07/2015
2	Pemetrexed (MTA)FDA Link 10/2019 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 04/2019 - 10/2017
2	Gemcitabine FDA Link 01/2017 - 03/2011
2	MicellesIBA 03/2012 - 06/2011
2	tocophersolanIBA 03/2012 - 06/2011
2	Folic Acid (Vitamin M)FDA LinkGeneric 07/2011 - 01/2010
1	Gingipain Cysteine EndopeptidasesIBA 04/2024
1	Chimeric Antigen ReceptorsIBA 04/2024
1	Nucleoside-Diphosphate KinaseIBA 04/2024
1	Smart MaterialsIBA 03/2024
1	AmmoniaIBA 03/2024
1	Antiviral Agents (Antivirals)IBA 01/2024
1	TeaIBA 01/2024
1	aluminum sulfate (alum)IBA 01/2024
1	Small Cytoplasmic RNAIBA 01/2024

Therapy/Procedure

23	Therapeutics 01/2024 - 03/2011
16	Drug Therapy (Chemotherapy) 01/2023 - 03/2011
9	Immunotherapy 01/2024 - 03/2015
5	Adjuvant Chemotherapy 01/2023 - 12/2014
2	Radiotherapy 02/2021 - 08/2013
2	Transplantation 10/2018 - 01/2017